ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

NCI expands program to promote healthy diet among African Americans.

September 24, 2004

DCPC Advisors Upset At NCAB Over Why Decision, But Move On

February 8, 1991

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

EMEND Improved Emesis In Men And Women, Trials Find

December 26, 2003

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004